Isomalto-oligosaccharide Market to Discern Positive Growth as Manufacturers Cont

Posted by Arslan on August 26th, 2019

A recent Fact.MR report finds that isomalto-oligosaccharide (IMO) sales in 2018 were ~420 thousand tons, and are estimated to record ~6% Y-o-Y in 2019. The IMO industry is primarily influenced by the ingredient’s benefits that extent beyond gastrointestinal tract, complemented by its growing popularity as a low-calorie sweetener in protein bars. Low glycemic index and high prebiotic fiber content in IMO has meant that adoption of this plant-based ingredient continues on an upward spiral in the supplements industry, to help health-conscious consumers achieve improved nutrient absorption and fat loss.

Stakeholders in the isomalto-oligosaccharide market are adopting innovative marketing strategies to attract a wider pool of audience. Stage-wise investment in product development and commercial campaigns for raising awareness on health benefits of IMO, by sharing successful results of clinical trials, are some of the key efforts of manufacturers that will augur well for the IMO market growth.

Request Free Sample Report Here:  https://www.factmr.com/connectus/sample?flag=S&rep_id=3751

Isomalto-oligosaccharide Market in Numbers

• The isomalto-oligosaccharide market is estimated to witness an incremental opportunity of US$ 590 Mn between 2019 and 2029. Demand for isomalto-oligosaccharide (IMO) is set to grow unabated, as ingredients with functional and nutritional benefits gain higher interest of food manufacturers.
• The IMO market is projected to register an impressive CAGR of ~7% through 2029.
• United States will remain the leading market for IMO, as the ingredient gains traction as the holy grail for functional food manufacturers, who focus on the uptake of growing consumer preference for fiber-rich diet.
• South Asia is expected to remain the high-growth market for IMO, as consumer awareness on clean-label ingredients grows abreast rising demand for low-carb, high-fiber and high-protein foods and beverages in the region.

Competition Landscape

The isomalto-oligosaccharide market will continue to witness the consolidation of four leading players, namely, Shandong Bailong Group Co., Ltd., Baolingbao Biology, Co. Ltd, Anhui Elite Industrial Co., Ltd., and BioNeutra Global Corporation - collectively accounting for ~70% market share.

The sugar-, fat-, and calorie-reduction is a growing trend in the food & beverage industry, which has led manufacturers to focus more on new product developments and innovation. Leading players are consolidating their market position further through strategic acquisitions and collaborations. For instance, in 2018, BioNeutra Global Corporation, a functional and health F&B ingredient manufacturer entered into a partnership with the nutritional division of LEHVOSS UK, Gee Lawson, to launch a novel isomalto-oligosaccharide product - VitaFiber(TM) IMO in Europe. In addition, key companies in IMO market are making significant investment in R&D activities, to improve the performance and functionality of IMO in animal feed.

The mid-level players, such as Shandong Tianjiao Biotech Co., Ltd., and Shijiazhuang Huachen Starch Sugar Production Co., Ltd., are eyeing geographical expansions to tap latent opportunities in developing markets. Growing focus of the market entrants on understanding consumer attitudes, knowledge, perceptions and behaviors, is likely to complement their permeation in the IMO market worldwide.

Key Challenges in the Isomalto-oligosaccharide Market 

• Pervasive permeation of probiotics as health supplements, backed by successful marketing activities, has overshadowed the prebiotics landscape, tugging sales of IMO as a consequence.
• High dose of isomalto oligosaccharide has been associated with adverse health impacts. The FDA recommends a maximum of 30 grams per day consumption of IMO. This is expected to pose a negative influence on growth of the IMO market.